共 12 条
[1]
[2]
[3]
[4]
[5]
[6]
[7]
Fasting Hyperglycemia Impairs Glucose- But Not Insulin-Mediated Suppression of Glucagon Secretion[J] Muhammad Abdul-Ghani;Ralph A. DeFronzo The Journal of Clinical Endocrinology & Metabolism 2007,
[8]
Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia[J] S. L. Conarello;G. Jiang;J. Mu;Z. Li;J. Woods;E. Zycband;J. Ronan;F. Liu;R. Sinha Roy;L. Zhu;M. J. Charron;B. B. Zhang Diabetologia 2006,
[9]
Vildagliptin; a Dipeptidyl Peptidase-IV Inhibitor; Improves Model-Assessed β-Cell Function in Patients with Type 2 Diabetes[J] A Mari;W M. Sallas;Y L. He;C Watson;M Ligueros-Saylan;B E. Dunning;C F. Deacon;J J. Holst;J E. Foley The Journal of Clinical Endocrinology & Metabolism 2005,
[10]
Glucagon as a target for the treatment of Type 2 diabetes[J] Sloop;Michael;Moyers Expert Opinion on Therapeutic Targets 2005,

